Journal
CURRENT STEM CELL RESEARCH & THERAPY
Volume 12, Issue 5, Pages 377-387Publisher
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1574888X12666170316105805
Keywords
Cardiovascular diseases; homing; hyperlipidemia; mesenchymal stem cells; osteogenic differentiation; proliferation
Categories
Ask authors/readers for more resources
Background: Various clinical studies have revealed that cardiovascular diseases (CVD) are associated with bone loss diseases such as osteoporosis and periodontitis, especially in older population. As one of the best-established risk factors of CVD, hyperlipidemia is also reported to interfere with the metabolism, function and regeneration of mineralized tissues. Derived from postnatal tissue reservoirs, mesenchymal stem cells (MSCs) are considered promising cell sources for mesenchymal and non-mesenchymal tissue regeneration based on their capacities for self-renewal and multi-lineage differentiation as well as potent immunosuppressive effects, secretion of cytokines and regulation of vascularization. MSCs could home to the injury sites from peripheral circulation, proliferate and differentiate into bone-forming cells, therefore significantly enhancing bone regeneration. However, elevated blood lipid levels affect the physiological behaviors of MSCs, as well as the performance of transplanted MSCs. Objective: This review aims to summarize the effects of hyperlipidemia and CVD on the proliferation, osteogenic differentiation and homing of MSCs. The principal observations of the underlying cellular and molecular mechanisms as well as the effects of lipid-lowering therapy on MSCs are also discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available